This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
9/3/2025
George Kopsiak
Moderator
Recording in progress. Welcome to the Lumos Diagnostics FY25 Results Investor Briefing. My name is George Kopsiak. I'll be your moderator for today. The webinar is being recorded today and will be made available on the Lumos website over the next couple of days. With us this morning, we have Lumos Diagnostics CEO, Doug Ward. We have CFO, Barry Lambert. Paul Case is the Senior Vice President of Commercial Operations. And Annie Bell is our Vice President of Medical Affairs. Good morning to you all. Morning, George.
Paul Case
Senior Vice President of Commercial Operations
Morning.
George Kopsiak
Moderator
So the format for today is for the team to walk you through the presentation that was released to the ASICs this morning. The presentation should take around 30 to 35 minutes. and this will then be followed by a question and answer session. If you'd like to ask a question, please click on the Q&A tab in the ribbon below, type your question in the box, and then I'll ask it on your behalf. That concludes housekeeping for today, so I'd like to now hand it over to Doug to get us started. Thank you, Doug.
You're reading a preview of the LDX.AX Q4 2025 earnings call.
Free account.
Disclaimer